Elder Care (Everybody)

Researchers have identified a crucial ion channel, TMEM175, that acts like an overflow valve in the cell’s recycling system. It regulates acidity inside lysosomes, ensuring they function properly. When TMEM175 is faulty, toxic buildup can occur, contributing to diseases like Parkinson’s. This breakthrough reveals a promising new target for future therapies.

Balance problems in aging and Parkinson’s may come from the body working too hard, not too little. Scientists found that the brain and muscles become overactive during even minor disturbances, yet this actually weakens balance recovery. At the same time, muscles can stiffen against each other, making movement less stable. This unexpected pattern could help predict who is more likely to fall.

A new study suggests a widely used bone hormone could help relieve chronic back pain in an unexpected way. Instead of just strengthening bone, it appears to stop pain-sensing nerves from growing into damaged spinal areas. In animal models, this led to stronger spinal tissue and reduced pain sensitivity. The findings hint at a future treatment that tackles back pain at its biological roots.

Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way to turn it off in mice. The culprit is a toxic pairing of two proteins that, when combined, triggers the destruction of brain cells and fuels memory loss. By using a new compound to break apart this deadly duo, researchers were able to slow disease progression, protect brain cells, and even reduce hallmark amyloid buildup.

Early life stress may set the stage for long-term digestive problems by disrupting the gut-brain connection. Studies in both mice and thousands of children found links to symptoms like pain, constipation, and IBS. Scientists discovered that different biological pathways control different gut issues, hinting at more personalized treatments in the future. The research also highlights how a child’s early environment can have lasting physical effects—not just emotional ones.

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the Fc fragment. This piece acts like a trigger, prompting microglia to clear harmful amyloid plaques. The finding could reshape how future Alzheimer’s therapies are designed.

A new UCLA Health study suggests that long-term exposure to the pesticide chlorpyrifos may dramatically raise the risk of Parkinson’s disease. Researchers found that people living in areas with sustained exposure had more than 2.5 times the likelihood of developing the disorder. Lab experiments reinforced the finding: animals exposed to the chemical developed movement problems, lost dopamine-producing neurons, and showed the same toxic protein buildup seen in Parkinson’s patients.

A new clinical study suggests that successful root canal treatment may benefit more than just dental health. Patients treated for infected teeth showed improved blood sugar control, healthier cholesterol levels, and reduced inflammation over time. The infection can allow bacteria to enter the bloodstream, potentially affecting metabolism and heart health. Clearing the infection appears to help reverse some of these harmful effects.

Melatonin is now widely used to help children sleep, but scientists say the enthusiasm may be getting ahead of the evidence. A major review found clear benefits for children with conditions like autism and ADHD, yet far less data exists for typical childhood insomnia. Researchers also warn about mislabeled supplement doses and rising accidental ingestions among young kids. Experts say melatonin should be used carefully and only alongside proven behavioral sleep strategies.

Tiny plastic particles may be quietly threatening brain health. New research suggests microplastics—now widely found in food, water, and even household dust—could trigger inflammation and damage in the brain through multiple biological pathways. Scientists estimate adults may consume about 250 grams of these particles each year, and some can accumulate in organs including the brain.

A new study suggests Alzheimer’s disease may be detectable through subtle shape changes in proteins found in the blood. Researchers discovered that structural differences in three blood proteins closely track the progression of the disease. By analyzing these changes in more than 500 people, the team was able to distinguish healthy individuals from those with mild cognitive impairment or Alzheimer’s with impressive accuracy. The approach could help move diagnosis and treatment to earlier stages.

Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody infusions like current therapies, the experimental treatment uses genetically engineered astrocytes — abundant support cells in the brain — that are equipped with a CAR “homing device” similar to those used in cancer immunotherapy.

Colorblindness may be doing more than making traffic lights confusing — it could also be hiding a life-threatening warning sign. Researchers analyzing millions of medical records found that people with bladder cancer who are also colorblind have a 52% higher mortality rate over 20 years compared to those with normal vision. The likely reason: many people with color vision deficiency struggle to see red, making it harder to notice blood in urine, the most common early sign of bladder cancer.

A new analysis of more than 422,000 patients reveals a stark Alzheimer’s care gap between Maryland’s urban and rural communities. Rural regions often lack hospitals and dementia specialists, forcing older patients to travel farther for diagnosis and treatment. Researchers found areas with high Alzheimer’s death rates but surprisingly low diagnosis rates, suggesting many cases may never be identified.

A massive UK study of more than 165,000 dementia patients has uncovered troubling new evidence about risperidone, a commonly used drug for severe agitation. Researchers found the antipsychotic increases stroke risk in dementia patients across the board—including those with no prior heart disease or stroke—challenging the long-held belief that some patients might be safer candidates than others. Because risperidone is the only drug of its type licensed for dementia, doctors often use it as a last resort when distressing symptoms become unmanageable.